Latest News about IMCR
Recent news which mentions IMCR
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
September 09, 2022
From Benzinga
Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply
September 09, 2022
From Benzinga
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday
September 09, 2022
From Benzinga
US Stocks Open Higher, Dow Surges 300 Points
September 09, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
September 08, 2022
From Benzinga
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday
September 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
From Benzinga
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
From Benzinga
From Benzinga
What's Winning in 2022? 3 Stocks That Are Doing Fine
July 16, 2022
From Motley Fool
From Benzinga
From Motley Fool
From Motley Fool
Immunocore Eye Cancer Cell Therapy Scores European Approval
April 04, 2022
Tickers
IMCR
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision
February 25, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
February 08, 2022
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
October 20, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.